Cedelizumab Biosimilar - Research Grade

Human

CD4ï؟½

5mg/ml

IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P01730

Blue ice

CD4 is a co-receptor on helper T cells central to MHC class II recognition and T-cell activation, making it a foundational target in immunology research. This antibody is an unconjugated, non-therapeutic analog of cedelizumab, a human IgG4-kappa recombinant monoclonal for research use only (RUO). It is delivered as an ultra-pure, low-endotoxin preparation meeting in vivo standards and produced in scalable milligram-to-gram quantities for high-throughput laboratories. It is suited to functional assays, T-cell activation and depletion studies, immune-cell phenotyping, in vitro screening and preclinical immune-modulation models examining CD4 biology.

CD4, CD4mut, CD4 molecule, OKT4D, IMD79

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks